{"nct_id":"NCT03909165","title":"Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2019-07-23","start_date_type":"ACTUAL","primary_completion_date":"2023-09-21","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-21","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["MRK"]}